This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Bar-Ilan University, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2026.
Company Filing History:
1 out of 244 
1 out of 910 
Years Active: 2026
Title: Sharon Etery: Innovator in Ophthalmological Research
Introduction: Sharon Etery is a notable inventor based in Rishon Le Tzion, Israel. She has made significant contributions to the field of ophthalmology through her research and innovative ideas. Although she currently holds no granted patents, her work is focused on developing advanced solutions for ocular health.
Latest Patent Applications: Sharon Etery's latest patent applications include two significant inventions. The first application is titled "Conjugates Comprising Ocular Angiogenesis Growth Factor Aptamers and Uses Thereof in the Detection and Treatment of Ophthalmological Angiogenesis Indications." This invention provides an antiangiogenic agent in the form of a vehicle, such as a nanoparticle associated with at least one ocular angiogenesis growth factor aptamer. The association is designed to be labile to interaction between the aptamer and an ocular angiogenesis growth factor. The second application is titled "Multi Drug Composite, Methods and Uses Thereof." This invention provides mesoporous nanoparticles loaded with at least one pharmaceutically active agent and at least one capping pharmaceutically active agent chemically coordinated with a ligand, such as boronic acid or its derivative, on the surface of the pores.
Conclusion: Sharon Etery is an innovative researcher whose work in ophthalmology holds promise for future advancements in the field. Her latest patent applications reflect her commitment to developing effective treatments for ocular conditions.